Geo Capital Gestora de Recursos Ltd lowered its position in CME Group Inc. (NASDAQ:CME - Free Report) by 41.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,329 shares of the financial services provider's stock after selling 5,277 shares during the quarter. CME Group comprises approximately 2.7% of Geo Capital Gestora de Recursos Ltd's portfolio, making the stock its 18th largest holding. Geo Capital Gestora de Recursos Ltd's holdings in CME Group were worth $1,944,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Wayfinding Financial LLC purchased a new position in CME Group in the first quarter worth $25,000. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares in the last quarter. Golden State Wealth Management LLC grew its position in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares in the last quarter. Alpine Bank Wealth Management purchased a new position in CME Group in the first quarter worth $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new position in CME Group in the first quarter worth $32,000. Institutional investors own 87.75% of the company's stock.
Analysts Set New Price Targets
Several research analysts recently issued reports on the stock. Citigroup upped their target price on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Piper Sandler upped their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Finally, Barclays set a $298.00 price target on shares of CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $261.93.
Read Our Latest Stock Report on CME Group
CME Group Trading Down 1.4%
NASDAQ CME traded down $3.80 during trading on Friday, hitting $269.52. 1,591,589 shares of the company's stock traded hands, compared to its average volume of 1,923,555. The stock has a fifty day moving average of $275.82 and a two-hundred day moving average of $268.31. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12-month low of $206.44 and a 12-month high of $290.79. The firm has a market cap of $97.13 billion, a P/E ratio of 26.09, a PEG ratio of 4.95 and a beta of 0.44.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.56 earnings per share. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is 48.40%.
Insider Activity
In other news, Director Charles P. Carey sold 500 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the transaction, the director directly owned 4,900 shares of the company's stock, valued at approximately $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard acquired 256 shares of the stock in a transaction dated Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the purchase, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.